MAS vs VNRX · P/E 18, rev $7.56B vs rev $1.4M
Masco Corporation (MAS) versus Volitionrx Ltd (VNRX) — a side-by-side from cached financials, not a winner call.
Masco Corporation (MAS) is a building products & equipment company listed on US.
Volitionrx Ltd (VNRX) is a medical devices company listed on AMEX.
Latest reported MAS revenue for 2025-12-31 was $7.56B. Net income was $810.0M. Revenue was down 3.4% from 2024-12-31 to 2025-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Latest reported VNRX revenue for 2026-06-30 was $1.4M. Net income was -$14.0M. Revenue was up 40.5% from 2026-03-31 to 2026-06-30. VNRX currently screens at market cap $15.9M.
MAS currently screens at market cap $14.00B and trailing P/E 18.1. VNRX currently screens at market cap $15.9M.
Not investment advice. Open the MAS and VNRX stock pages for the full models.
Not investment advice.